Page last updated: 2024-08-23

loceryl and Nail Fungus

loceryl has been researched along with Nail Fungus in 86 studies

Research

Studies (86)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	13 (15.12)	18.2507
2000's	28 (32.56)	29.6817
2010's	36 (41.86)	24.3611
2020's	9 (10.47)	2.80

Authors

Authors	Studies
Blume-Peytavi, U; Carreño, C; Falqués, M; Galván, J; Tamarit, ML; Tebbs, V; Tosti, A	1
Barrett, J; Boal, CWC; Brennan, J; Callanan, S; Ehrensberger, M; Makarus, J; Patton, T; Spillane, E	1
Almeida, BCT; Baltazar, LM; Carmo, PHF; Dornelas, JCM; Ferreira, GF; Freitas, GJC; Peres, NTA; Santos, DA	1
Nagesha, PC; Rangegowda, SM; Ravikumar, BC; Shetty, P; Vinay, KN	1
Bunyaratavej, S; Chanyachailert, P; Kiratiwongwan, R; Kobwanthanakun, W; Leeyaphan, C; Limphoka, P; Nokdhes, YN; Patthamalai, P; Suphatsathienkul, P; Tantrapornpong, P; Ungaksornpairote, C; Wanitphakdeedecha, R	1
Bagger, C; Endringer Pinto, F; Janfelt, C; Joly-Tonetti, N; Kunze, G; Osman-Ponchet, H; Thénot, JP	1
Cai, W; Huang, H; Li, J; Lu, S; Qin, J; Xi, L; Yang, S; Zhang, J; Zhang, Y	1
Asawanonda, P; Boontaveeyuwat, E; Bowornsathitchai, N; Kitsongsermthon, J; Shoosanglertwijit, J; Thammahong, A; Wititsuwannakul, J	1
Bunyaratavej, S; Kiratiwongwan, R; Leeyaphan, C; Srinonprasert, V; Wongdama, S	1
Dyląg, M; Hryncewicz-Gwóźdź, A; Jagielski, T	1
Sarkany, M; Schaller, M; Sigurgeirsson, B	1
Artzi, O; Koren, A; Salameh, F; Sprecher, E	1
Dhamoon, RK; Gupta, M; Popli, H	1
Ambrogio, F; Bonamonte, D; De Prezzo, S; Foti, C; Hansel, K; Romita, P; Stingeni, L	1
Ben Osman, A; Bienvenu, AL; Bulai-Livideanu, C; Cazeau, C; Coubetergues, H; Coustou, D; Doss, N; Fazaa, B; Lahfa, M; Mokthar, I; Nouira, R; Paul, C; Picot, S; Turki, H; Voisard, JJ; Zourabichvili, O	1
Arendrup, MC; Haugaard, LK; Saunte, DM; Skov, L	1
Fukushima, S; Ihn, H; Ikeda, I; Makino, T; Miyazaki, Y; Nishimoto, K; Ohno, H; Ohno, T	1
Lipner, S; Scher, RK	1
Im, M; Kim, CD; Kim, HR; Lee, JH; Lee, Y; Lim, EH; Park, YO; Seo, YJ	1
Fothergill, AW; McCarthy, DI; Tavakkol, A; Wiederhold, NP	1
Chen, S; Dai, YL; Hu, WY; Lama, J; Ran, YP	1
Auvinen, T; Jokinen, JJ; Sipponen, A; Soini, M; Tiihonen, R; Wangel, M	1
Borelli, C; Jäckel, A; Müller, J; Polak, A; Schaller, M; Seidl, HP	1
Borelli, C; Braunsdorf, C; Jäckel, A; Mailänder-Sanchez, D; Müller, J; Schaller, M	1
Bunyaratavej, S; Leeyaphan, C; Matthapan, L; Muanprasat, C; Rujitharanawong, C; Surawan, TM	1
Cos, P; Delputte, P; Lanckacker, E; Maes, L; Sleven, R	1
Ghannoum, MA; Kerrouche, N; Osman-Ponchet, H; Sidou, F; Sigurgeirsson, B	1
Hossin, B; Murdan, S; Rizi, K	1
Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A	1
Brown, MB; Guesné, S; Jones, SA; McAuley, WJ; Murdan, S; Traynor, MJ	1
Cai, W; Huang, H; Li, X; Lu, S; Ma, J; Xi, L; Zhang, J	1
Brown, M; Kondori, N; Stensen, W; Svendsen, JS; Svenson, J; Turner, R	1
Feng, X; Ran, Y; Xiong, X	1
Eichenfield, LF; Friedlander, SF	1
Carrillo-Muñoz, AJ; Del Valle, O; Eraso, E; Ezkurra, PA; Giusiano, G; Guardia, C; Hernández-Molina, JM; Quindós, G; Santos, P; Tur-Tur, C	1
Cantrell, W; Cathcart, S; Elewski, Be	1
Budihardja, D; Freund, V; Mayser, P	1
Burgalassi, S; Chetoni, P; Ghelardi, E; Mailland, F; Monti, D; Saccomani, L; Senesi, S	1
Berger, U; Borelli, C; Jäckel, A; Schaller, M; Schmidt, S; Walker, B; Weindl, G	1
Kerrouche, N; Olafsson, JH; Sidou, F; Sigurgeirsson, B; Steinsson, JT	1
Baudraz-Rosselet, F; Bontems, O; Lurati, M; Monod, M; Ruffieux, C	1
Piraccini, BM; Sisti, A; Tosti, A	1
Vera-Cabrera, L; Welsh, E; Welsh, O	1
Brown, MB; Evans, CR; Jones, SA; Khengar, RH; Traynor, MJ; Turner, RB	1
Kubota, N; Mukai, H; Nagasaka, S; Shibuya, K; Shimamura, T; Suzuki, T	1
Dal Bo, L; Herranz, U; Monti, D; Subissi, A	1
Fayet-Pérez, A; Martínez-Plata, E; Molina-Arrebola, MA; Morales-Molina, JA; Pérez-Moyano, R	1
Fothergill, A; Jo Siu, WJ; Nakamura, T; Pillai, R; Senda, H; Sone, D; Tatsumi, Y	1
Lorenzi, S; Piraccini, BM; Tosti, A	1
Kakehi, K; Senda, H; Tatsumi, Y; Yokoo, M	1
Ito, T; Majima, T; Nakashima, T; Nozawa, A	1
Balkou, P; Bolbasis, I; Christofidou, E; Fragouli, E; Georgala, S; Ioannides, D; Kalogeromitros, D; Karistinou, A; Katoulis, AC; Katsambas, AD; Polydorou, D; Rigopoulos, D	1
Baran, R; Gupta, AK; Ryder, JE	1
Lambert, J	1
Austel, U	1
Reinel, D	2
Thomas, CL	1
Ratajczak-Stefańska, V	1
Sidou, F; Soto, P	1
Baran, R; Kaoukhov, A	1
Flagothier, C; Piérard, GE; Piérard-Franchimont, C	1
Adjadj, L; Jäckel, A; Lambert, J; Marty, JP	1
Adamski, Z; Maleszka, R	1
Baran, R; de Berker, D; Faergemann, J; Kaufmann, R; Kerrouche, N; Lecha, M; Sidou, F; Sigurgeirsson, B	1
Gupta, AK; Sauder, DN; Shear, NH	1
Bryson, HM; Haria, M	1
Reckers-Czaschka, R	1
Cohen, PR; Scher, RK	1
Hernanz Hermosa, JM; Lázaro Ochaita, P	1
Cork, MJ; Haycox, A; Humphrey, KM	1
Archer, CB; Downs, AM; Lear, JT	1
Badillet, G; Baran, R; Combernale, P; Czernielewski, J; Datry, A; Feuilhade, M; Goettmann, S; Larnier, C; Pietrini, P; Viguie, C	1
Arrese, JE; Pierard, GE; Pierard-Franchimont, C	1
Almagro, M; del Pozo, J; Fonseca, E; García-Silva, J; Peña-Penabad, C	1
Martínez, R; Millán, R; Orden, B; Roustan, G	1
Baran, R	2
Lecha, M	1
Evans, EG	1
Seebacher, C	1
Erni, W; Gerhards, J; Klecak, G; Pittrof, F	1
Mensing, H; Polak-Wyss, A; Splanemann, V	1
Clarke, C; Reinel, D	1
Bergstraesser, M; Zaug, M	1

Reviews

15 review(s) available for loceryl and Nail Fungus

Article	Year
Novel Drug Delivery Strategies for the Treatment of Onychomycosis. Pharmaceutical nanotechnology, 2019, Volume: 7, Issue:1 Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Drug Carriers; Humans; Liposomes; Morpholines; Nail Diseases; Nanoparticles; Onychomycosis	2019
Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review. Dermatologic therapy, 2017, Volume: 30, Issue:3 Topics: Administration, Topical; Antifungal Agents; Drug Therapy, Combination; Humans; Itraconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Terbinafine	2017
Pediatric Onychomycosis: The Emerging Role of Topical Therapy. Journal of drugs in dermatology : JDD, 2017, 02-01, Volume: 16, Issue:2 Topics: Administration, Topical; Adult; Age Factors; Antifungal Agents; Child; Ciclopirox; Family; Humans; Imidazoles; Incidence; Ketoconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Recurrence; Terbinafine; Tinea Pedis; Treatment Outcome	2017
Onychomycosis and diabetes. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:10 Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Diabetes Complications; Humans; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine	2009
Toenail onychomycosis in diabetic patients: issues and management. American journal of clinical dermatology, 2009, Volume: 10, Issue:4 Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome	2009
Onychomycosis. Clinics in dermatology, 2010, Mar-04, Volume: 28, Issue:2 Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole	2010
The use of topical therapies to treat onychomycosis. Dermatologic clinics, 2003, Volume: 21, Issue:3 Topics: Administration, Cutaneous; Antifungal Agents; Ciclopirox; Humans; Morpholines; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic	2003
Pharmacoeconomic issues in onychomycosis. The British journal of dermatology, 2003, Volume: 149 Suppl 65 Topics: Antifungal Agents; Drug Costs; Humans; Morpholines; Onychomycosis	2003
Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:1 Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Morpholines; Onychomycosis; Pyridones; Risk Factors	2005
New insights into the effect of amorolfine nail lacquer. Mycoses, 2005, Volume: 48, Issue:2 Topics: Administration, Topical; Antifungal Agents; Fungi; Humans; Morpholines; Onychomycosis; Spores, Fungal	2005
Antifungal agents: an overview. Part II. Journal of the American Academy of Dermatology, 1994, Volume: 30, Issue:6 Topics: Allylamine; Antifungal Agents; Azoles; Dermatomycoses; Humans; Morpholines; Naphthalenes; Onychomycosis; Terbinafine	1994
Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. Drugs, 1995, Volume: 49, Issue:1 Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Dermatomycoses; Female; Humans; Microbial Sensitivity Tests; Morpholines; Onychomycosis	1995
Topical and surgical treatment of onychomycosis. Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 2 Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Combined Modality Therapy; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Onychomycosis; Pyridones	1994
[Superficial mycoses in immunosuppressed patients]. Revista clinica espanola, 1995, Volume: 195 Suppl 3 Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles	1995
The rationale for combination therapy. The British journal of dermatology, 2001, Volume: 145 Suppl 60 Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Cell Wall; Drug Therapy, Combination; Ergosterol; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Recurrence; Terbinafine	2001

Trials

25 trial(s) available for loceryl and Nail Fungus

Article	Year
A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis. Mycoses, 2022, Volume: 65, Issue:4 Topics: Antifungal Agents; Double-Blind Method; Foot Dermatoses; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Terbinafine; Treatment Outcome	2022
A clinical study for the treatment of onychomycosis patients using a novel ROS producing onychomycosis treatment when compared against 5% amorolfine topical lacquer to reduce the visible size of infected toenails. Journal de mycologie medicale, 2022, Volume: 32, Issue:3 Topics: Administration, Topical; Antifungal Agents; Foot Dermatoses; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Reactive Oxygen Species; Treatment Outcome	2022
Comparative study of safety and efficacy of combination therapy of fractional CO Lasers in medical science, 2023, Jun-24, Volume: 38, Issue:1 Topics: Antifungal Agents; Carbon Dioxide; Humans; Itraconazole; Lasers, Gas; Onychomycosis; Treatment Outcome	2023
Randomized controlled trial comparing long-pulsed 1064-Nm neodymium: Yttrium-aluminum-garnet laser alone, topical amorolfine nail lacquer alone, and a combination for nondermatophyte onychomycosis treatment. Journal of cosmetic dermatology, 2020, Volume: 19, Issue:9 Topics: Aluminum; Antifungal Agents; Humans; Lacquer; Lasers, Solid-State; Morpholines; Neodymium; Onychomycosis; Treatment Outcome; Yttrium	2020
Comparison of a fractional 2940-nm Er:YAG laser and 5% amorolfine lacquer combination therapy versus a 5% amorolfine lacquer monotherapy for the treatment of onychomycosis: a randomized controlled trial. Lasers in medical science, 2021, Volume: 36, Issue:1 Topics: Adult; Antifungal Agents; Combined Modality Therapy; Female; Humans; Lacquer; Lasers, Solid-State; Male; Morpholines; Nails; Onychomycosis; Patient Satisfaction; Treatment Outcome	2021
Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis. Mycoses, 2017, Volume: 60, Issue:12 Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Imidazoles; Lacquer; Male; Medication Adherence; Middle Aged; Morpholines; Onychomycosis; Patient Reported Outcome Measures; Pyridones	2017
Laser-assisted Photodynamic Therapy or Laser-assisted Amorolfine Lacquer Delivery for Treatment of Toenail Onychomycosis: An Open-label Comparative Study. Acta dermato-venereologica, 2018, Apr-16, Volume: 98, Issue:4 Topics: Adult; Aged; Aminolevulinic Acid; Antifungal Agents; Female; Foot Dermatoses; Humans; Lacquer; Lasers, Gas; Male; Middle Aged; Morpholines; Onychomycosis; Photochemotherapy; Photosensitizing Agents; Remission Induction; Time Factors; Treatment Outcome	2018
A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in Dermatology (Basel, Switzerland), 2013, Volume: 227, Issue:2 Topics: Adolescent; Adult; Aged; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Foot Dermatoses; Humans; Male; Middle Aged; Morpholines; Ointments; Onychomycosis; Pyridones; Retrospective Studies; Skin Cream; Time Factors; Treatment Outcome; Young Adult	2013
Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial. The British journal of dermatology, 2015, Volume: 173, Issue:4 Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Lacquer; Male; Morpholines; Naphthalenes; Onychomycosis; Prospective Studies; Resins, Plant; Single-Blind Method; Terbinafine; Treatment Outcome; Young Adult	2015
Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays. Mycoses, 2016, Volume: 59, Issue:5 Topics: Adult; Aged; Antifungal Agents; Cadaver; Cosmetics; Female; Foot Dermatoses; Humans; Male; Middle Aged; Morpholines; Onychomycosis	2016
Combination therapy for onychomycosis using a fractional 2940-nm Er:YAG laser and 5 % amorolfine lacquer. Lasers in medical science, 2016, Volume: 31, Issue:7 Topics: Adult; Aged; Aluminum; Antifungal Agents; Combined Modality Therapy; Erbium; Female; Follow-Up Studies; Humans; Lacquer; Lasers, Solid-State; Male; Middle Aged; Morpholines; Nails; Onychomycosis; Young Adult; Yttrium	2016
Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:8 Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Lacquer; Longitudinal Studies; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Pilot Projects; Secondary Prevention; Terbinafine; Treatment Outcome	2010
Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects. Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27, Issue:2 Topics: Adult; Ciclopirox; Humans; Male; Middle Aged; Morpholines; Nails; Onychomycosis; Pyridones; Reference Values	2013
A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis. The British journal of dermatology, 2003, Volume: 149, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis; Drug Administration Schedule; Drug Therapy, Combination; Female; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Morpholines; Onychomycosis; Prospective Studies; Treatment Outcome	2003
[Assessment of mycological and clinical factors on the course and results of treatment of mycotic infections in patients with recurrent onychomycosis]. Annales Academiae Medicae Stetinensis, 2003, Volume: 49 Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Epidermophyton; Humans; Itraconazole; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Pentoxifylline; Recurrence; Terbinafine; Treatment Outcome; Trichophyton	2003
A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers. International journal of tissue reactions, 2004, Volume: 26, Issue:1-2 Topics: Adult; Antifungal Agents; Ciclopirox; Female; Humans; Imidazoles; Lacquer; Male; Morpholines; Nails; Onychomycosis; Pyridones; Soaps; Thumb	2004
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix invol The British journal of dermatology, 2007, Volume: 157, Issue:1 Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Hand Dermatoses; Humans; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Terbinafine	2007
A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. The British journal of dermatology, 2000, Volume: 142, Issue:6 Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Drug Synergism; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome	2000
The boosted antifungal topical treatment (BATT) for onychomycosis. Medical mycology, 2000, Volume: 38, Issue:5 Topics: Administration, Topical; Adult; Agar; Antifungal Agents; Combined Modality Therapy; Culture Media; Humans; Middle Aged; Morpholines; Nails; Onychomycosis; Pilot Projects; Spores, Fungal; Trichophyton	2000
Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis. The British journal of dermatology, 2001, Volume: 145 Suppl 60 Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Foot Dermatoses; Humans; Morpholines; Naphthalenes; Onychomycosis; Terbinafine	2001
Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain. The British journal of dermatology, 2001, Volume: 145 Suppl 60 Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Drug Costs; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Morpholines; Onychomycosis; Treatment Outcome; Trichophyton	2001
Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations. Clinical and experimental dermatology, 1992, Volume: 17 Suppl 1 Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Lacquer; Male; Middle Aged; Morpholines; Nails; Onychomycosis; Skin Absorption	1992
Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly. Clinical and experimental dermatology, 1992, Volume: 17 Suppl 1 Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lacquer; Male; Middle Aged; Morpholines; Onychomycosis	1992
Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview). Clinical and experimental dermatology, 1992, Volume: 17 Suppl 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Dermatomycoses; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Onychomycosis; Random Allocation; Treatment Outcome	1992
Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use. Dermatology (Basel, Switzerland), 1992, Volume: 184 Suppl 1 Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Tolerance; Female; Foot Dermatoses; Humans; Lacquer; Male; Middle Aged; Morpholines; Onychomycosis; Random Allocation	1992

Other Studies

46 other study(ies) available for loceryl and Nail Fungus

Article	Year
Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale. Medical mycology, 2022, Aug-18, Volume: 60, Issue:8 Topics: Animals; Antifungal Agents; Arthrodermataceae; Ciclopirox; Ergosterol; Microbial Sensitivity Tests; Morpholines; Nitrogen; Onychomycosis; Oxygen; Reactive Oxygen Species; Superoxide Dismutase; Trichophyton	2022
Visualisation of penetration of topical antifungal drug substances through mycosis-infected nails by matrix-assisted laser desorption ionisation mass spectrometry imaging. Mycoses, 2020, Volume: 63, Issue:8 Topics: Administration, Topical; Allylamine; Antifungal Agents; Ciclopirox; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2020
Methylene blue-mediated photodynamic therapy may be superior to 5% amorolfine nail lacquer for non-dermatophyte onychomycosis. Photodermatology, photoimmunology & photomedicine, 2021, Volume: 37, Issue:3 Topics: Antifungal Agents; Humans; Lacquer; Methylene Blue; Morpholines; Nails; Onychomycosis; Photochemotherapy; Treatment Outcome	2021
Onychomycosis in older adults: The age and associated factors affecting the complete cure rate. The Australasian journal of dermatology, 2022, Volume: 63, Issue:1 Topics: Aged; Antifungal Agents; Antihypertensive Agents; Cohort Studies; Female; Foot Dermatoses; Humans; Kidney Diseases; Male; Middle Aged; Morpholines; Onychomycosis; Peripheral Arterial Disease; Polypharmacy; Retrospective Studies; Sex Factors; Smoking; Thailand	2022
Onychomycosis Due to Arthrinium arundinis: A Case Report. Acta dermato-venereologica, 2017, Jul-06, Volume: 97, Issue:7 Topics: Adult; Antifungal Agents; Ascomycota; Drug Therapy, Combination; Foot Dermatoses; Humans; Itraconazole; Male; Microscopy, Electron, Scanning; Morpholines; Onychomycosis; Remission Induction; Treatment Outcome	2017
Allergic contact dermatitis caused by amorolfine in a nail lacquer. Contact dermatitis, 2019, Volume: 81, Issue:5 Topics: Administration, Topical; Antifungal Agents; Dermatitis, Allergic Contact; Female; Humans; Middle Aged; Morpholines; Onychomycosis	2019
[Onychomycosis is rare in young children, and treatment is a task for dermatological specialists]. Ugeskrift for laeger, 2013, Sep-30, Volume: 175, Issue:40 Topics: Antifungal Agents; Child, Preschool; Female; Foot Dermatoses; Humans; Morpholines; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Trichophyton	2013
Case of Fusarium paronychia successfully treated with occlusive dressing of antifungal cream. The Journal of dermatology, 2014, Volume: 41, Issue:4 Topics: Adult; Antifungal Agents; Behcet Syndrome; Fusariosis; Fusarium; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Morpholines; Occlusive Dressings; Onychomycosis	2014
Onychomycosis: current and future therapies. Cutis, 2014, Volume: 93, Issue:2 Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles	2014
Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream. Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:5 Topics: Adult; Aged; Antifungal Agents; Combined Modality Therapy; Female; Humans; Lasers, Gas; Male; Middle Aged; Morpholines; Onychomycosis; Skin Cream	2014
Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dermatomycoses; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine	2014
Case of infantile onychomycosis successfully cured by 5% amorolfine nail lacquer. Journal of paediatrics and child health, 2014, Volume: 50, Issue:11 Topics: Administration, Topical; Follow-Up Studies; Foot Dermatoses; Humans; Infant; Lacquer; Male; Morpholines; Onychomycosis; Severity of Illness Index; Treatment Outcome	2014
Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections. Mycoses, 2015, Volume: 58, Issue:10 Topics: Antifungal Agents; Candida albicans; Ciclopirox; Epidermophyton; Fluconazole; Hand Dermatoses; Humans; Keratins; Microbial Sensitivity Tests; Morpholines; Nails; Naphthalenes; Onychomycosis; Pyridones; Spores, Fungal; Terbinafine; Trichophyton	2015
Comparison of user-friendliness and treatment cost of Loceryl® vs. Ciclopoli®--a patient's perspective. Mycoses, 2015, Volume: 58, Issue:10 Topics: Administration, Topical; Adult; Antifungal Agents; Ciclopirox; Foot Dermatoses; Germany; Health Care Costs; Humans; Male; Morpholines; Nails; Onychomycosis; Patient Satisfaction; Prospective Studies; Pyridones; Surveys and Questionnaires	2015
Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis. The Journal of dermatological treatment, 2016, Volume: 27, Issue:4 Topics: Administration, Topical; Adult; Antifungal Agents; Female; Humans; Lacquer; Male; Middle Aged; Morpholines; Onychomycosis; Retrospective Studies; Treatment Outcome	2016
Evaluation of topical antifungal products in an in vitro onychomycosis model. Mycoses, 2016, Volume: 59, Issue:5 Topics: Administration, Topical; Agar; Animals; Antifungal Agents; Cattle; Cosmetics; Disease Models, Animal; Hoof and Claw; Immunodiffusion; Morpholines; Onychomycosis; Trichophyton	2016
Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2016, Volume: 102 Topics: Adolescent; Adult; Antifungal Agents; Ciclopirox; Drug Interactions; Female; Humans; Keratins; Male; Middle Aged; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Pharmaceutical Preparations; Pyridones; Solubility; Terbinafine; Triazoles; Young Adult	2016
Onychomycosis: Strategies to Minimize Recurrence. Journal of drugs in dermatology : JDD, 2016, Volume: 15, Issue:3 Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles	2016
An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2016, Volume: 102 Topics: Administration, Topical; Antifungal Agents; Humans; Keratins; Morpholines; Mycoses; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Permeability; Skin; Terbinafine; Water	2016
Short Cationic Antimicrobial Peptides Display Superior Antifungal Activities toward Candidiasis and Onychomycosis in Comparison with Terbinafine and Amorolfine. Molecular pharmaceutics, 2016, 10-03, Volume: 13, Issue:10 Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Candida albicans; Candidiasis; Humans; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Skin Diseases; Terbinafine	2016
In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:4 Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dose-Response Relationship, Drug; Fluconazole; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Thiophenes; Yeasts	2008
Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity. The British journal of dermatology, 2010, Feb-01, Volume: 162, Issue:2 Topics: Absorption; Administration, Topical; Animals; Antifungal Agents; Cattle; Ciclopirox; Hoof and Claw; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Permeability; Pharmaceutical Solutions; Pharmaceutical Vehicles; Pyridones; Regression Analysis; Solubility	2010
Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. Medical mycology, 2009, Volume: 47, Issue:7 Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Humans; Imidazoles; Microbial Sensitivity Tests; Models, Biological; Morpholines; Onychomycosis; Pyridones; Trichophyton	2009
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents. Dermatology (Basel, Switzerland), 2010, Volume: 220, Issue:2 Topics: Acremonium; Adult; Antifungal Agents; Aspergillus; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Polymorphism, Restriction Fragment Length; Terbinafine	2010
Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:3 Topics: Adult; Aged; Antifungal Agents; Arthrodermataceae; Female; Foot Dermatoses; Humans; Itraconazole; Lacquer; Male; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Terbinafine; Treatment Outcome	2010
Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents. The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:6 Topics: Adenosine Triphosphate; Administration, Topical; Antifungal Agents; Cadaver; Ciclopirox; Humans; In Vitro Techniques; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Permeability; Pyridones; Terbinafine	2010
Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7 Topics: Animals; Antifungal Agents; Ciclopirox; Lacquer; Male; Models, Biological; Morpholines; Onychomycosis; Pyridones; Rabbits; Trichophyton	2011
Interaction between amorolfine and acenocoumarol. European journal of clinical pharmacology, 2012, Volume: 68, Issue:12 Topics: Acenocoumarol; Aged; Anticoagulants; Antifungal Agents; Aortic Valve; Drug Interactions; Female; Heart Valve Prosthesis; Humans; International Normalized Ratio; Middle Aged; Morpholines; Onychomycosis	2012
[When the nail is the polished one]. MMW Fortschritte der Medizin, 2012, May-31, Volume: 154, Issue:10 Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Combined Modality Therapy; Disease Progression; Humans; Morpholines; Onychomycosis; Pyridones	2012
Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4 Topics: Antifungal Agents; Aspergillus; Candida; Cryptococcus; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pseudallescheria; Scopulariopsis; Terbinafine; Triazoles; Trichophyton; Trichosporon	2013
'Deep' white superficial onychomycosis due to molds. Journal of the European Academy of Dermatology and Venereology : JEADV, 2002, Volume: 16, Issue:5 Topics: Administration, Topical; Antifungal Agents; Aspergillus; Humans; Male; Middle Aged; Morpholines; Onychomycosis	2002
Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:12 Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Guinea Pigs; Male; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis; Triazoles; Trichophyton	2002
Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2002, Volume: 8, Issue:4 Topics: Adult; Antifungal Agents; Female; Humans; Imidazoles; Male; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Pyridines; Terbinafine; Thiones; Trichophyton	2002
[Dual therapy of onychomycoses. Only Schwaben Province physicians also think of costs]. MMW Fortschritte der Medizin, 2003, Oct-09, Volume: 145, Issue:41 Topics: Administration, Topical; Antifungal Agents; Cost Control; Drug Costs; Drug Therapy, Combination; Germany; Humans; Morpholines; Naphthalenes; National Health Programs; Onychomycosis; Terbinafine	2003
[Onychomycosis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:2 Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors	2004
Combination treatment of candidal fingernail onychomycosis. The British journal of dermatology, 2004, Volume: 150, Issue:6 Topics: Antifungal Agents; Candidiasis; Drug Costs; Drug Therapy, Combination; Humans; Itraconazole; Morpholines; Onychomycosis	2004
Treatment costs of three nail lacquers used in onychomycosis. The Journal of dermatological treatment, 2005, Volume: 16, Issue:5-6 Topics: Adult; Antifungal Agents; Ciclopirox; Drug Costs; Europe; Female; Foot Dermatoses; Hand Dermatoses; Humans; Imidazoles; Male; Morpholines; Onychomycosis; Pyridones	2005
[The treatment of extensive onychomycosis in aged patients]. Wiadomosci parazytologiczne, 2001, Volume: 47, Issue:4 Topics: Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Morpholines; Nails; Onychomycosis; Treatment Outcome	2001
[Comment on the contribution by E. Haneke. Therapy of nail mycoses]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1994, Volume: 45, Issue:6 Topics: Administration, Topical; Antifungal Agents; Dose-Response Relationship, Drug; Humans; Morpholines; Onychomycosis	1994
A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practice. The British journal of dermatology, 1998, Volume: 139, Issue:4 Topics: Antifungal Agents; Cost-Benefit Analysis; England; Family Practice; Griseofulvin; Humans; Imidazoles; Morpholines; Naphthalenes; Onychomycosis; Referral and Consultation; Retrospective Studies; Terbinafine	1998
Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer. The British journal of dermatology, 1999, Volume: 140, Issue:3 Topics: Administration, Topical; Antifungal Agents; Humans; Lacquer; Male; Middle Aged; Morpholines; Onychomycosis	1999
Superficial white onychomycosis in a 3-year-old human immunodeficiency virus-infected child. Journal of the European Academy of Dermatology and Venereology : JEADV, 2001, Volume: 15, Issue:1 Topics: Antifungal Agents; Child, Preschool; Female; HIV Infections; Humans; Morpholines; Onychomycosis	2001
[Leukonychia: whitish pigmentation of the ungueal lamina]. Enfermedades infecciosas y microbiologia clinica, 2001, Volume: 19, Issue:9 Topics: Antifungal Agents; Coloring Agents; Fusarium; Hepatitis C, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Morpholines; Onychomycosis; Pigmentation Disorders; Toes; Urticaria Pigmentosa	2001
[Fungal nail diseases. What the pharmacist can do for his clients]. Medizinische Monatsschrift fur Pharmazeuten, 2001, Volume: 24, Issue:12 Topics: Administration, Topical; Antifungal Agents; Humans; Morpholines; Onychomycosis; Pharmacists	2001
[New treatments of onychomycoses]. Annales de dermatologie et de venereologie, 1992, Volume: 119, Issue:3 Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones	1992
Loceryl nail lacquer--realization of a new galenical approach to onychomycosis therapy. Clinical and experimental dermatology, 1992, Volume: 17 Suppl 1 Topics: Administration, Topical; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Lacquer; Morpholines; Nails; Onychomycosis; Skin Absorption	1992